You are right that it is not a competitor, not least as there is no way to fund human clinical trial of Losartan as a cardioprotective agent. There are literally dozen of drugs that have been discovered to be cardioprotective in preclinical models and zero of them have made it to approval for this purpose.
Cardioprotection thread, page-781
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.115(6.28%) |
Mkt cap ! $294.7M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.70 | $240.2K | 138.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 3000 | 1 |
View Market Depth
| Last trade - 15.58pm 22/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |